Health Catalyst (HCAT) Return on Equity (2019 - 2025)
Health Catalyst's Return on Equity history spans 7 years, with the latest figure at 0.62% for Q4 2025.
- For Q4 2025, Return on Equity fell 42.0% year-over-year to 0.62%; the TTM value through Dec 2025 reached 0.62%, down 42.0%, while the annual FY2025 figure was 0.58%, 39.0% down from the prior year.
- Return on Equity reached 0.62% in Q4 2025 per HCAT's latest filing, down from 0.32% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 0.19% in Q4 2024 to a low of 0.62% in Q4 2025.
- Average Return on Equity over 5 years is 0.33%, with a median of 0.32% recorded in 2025.
- Peak YoY movement for Return on Equity: rose 19bps in 2022, then tumbled -42bps in 2025.
- A 5-year view of Return on Equity shows it stood at 0.29% in 2021, then dropped by -11bps to 0.32% in 2022, then rose by 1bps to 0.32% in 2023, then skyrocketed by 39bps to 0.19% in 2024, then crashed by -219bps to 0.62% in 2025.
- Per Business Quant, the three most recent readings for HCAT's Return on Equity are 0.62% (Q4 2025), 0.32% (Q3 2025), and 0.28% (Q2 2025).